BioSpace News Archive

Business

Clinical Innovations hires Richard Ji as vice president of operations

Clinical Innovations today announced the hiring of Richard Ji as its new vice president of operations.

July 23, 2018
·
3 min read
Deals

Pre-Market Research Reports on Generic Drugs Stocks -- Tricida, Zoetis, Adamas Pharma, and Allergan

On Friday, key US indices were bearish as the NASDAQ Composite finished the trading session down 0.07%; the Dow Jones Industrial Average edged 0.03% lower; and the S&P 500 was down 0.09%.

July 23, 2018
·
7 min read
FDA

IDT’s Customer Senseonics Receives FDA Approval for its Implantable Glucose Sensor

Integrated Device Technology, Inc. announced that its customer Senseonics (Germantown, MD) received FDA approval for its Eversense® Continuous Glucose Monitoring (CGM) System for people with diabetes.

July 23, 2018
·
4 min read
Policy

Aerie Pharmaceuticals Announces Early Notification of FDA Acceptance of NDA Submission for Roclatan™ (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% with PDUFA Date Set for March 14, 2019

Aerie Pharmaceuticals, Inc. reported that it has received the “Day 74” notification from the U.S. Food and Drug Administration (FDA) earlier than scheduled, the FDA has completed its initial 60-day review of the NDA (new drug application) for Roclatan™

July 23, 2018
·
7 min read
Pharm Country

Lannett Announces Multiple Product Launches

Lannett Company, Inc. announced that it launched four products in June 2018, bringing to seven the total number of products launched since January 1, 2018.

July 23, 2018
·
2 min read
Business

NanoViricides, Inc. Welcomes Dr. Irach Taraporewala as the New CEO

NanoViricides, Inc.is pleased to announce that the Company’s Board has appointed Dr. Irach Taraporewala as the new Chief Executive Officer (CEO).

July 23, 2018
·
4 min read
BioCapital

Disarm Therapeutics Presents Data Demonstrating the Protective Effect of SARM1 Deletion on Axonal Degeneration

SARM1 deletion protects axons and prevents increases in neurofilament light chain (NF-L), a biomarker of axonal degeneration

July 23, 2018
·
3 min read
Drug Development

Sangamo Announces Treatment Of First Patient In Phase 1/2 Clinical Trial Evaluating SB-318 Investigational In Vivo Genome Editing Therapy For MPS I

Sangamo Therapeutics, Inc. announced treatment of the first patient in the Phase 1/2 clinical trial evaluating SB-318, an investigational in vivo genome editing therapy for patients with mucopolysaccharidosis type I

July 23, 2018
·
4 min read
Drug Development

Alzheon Presents New Findings in APOE4/4 Homozygous Patients with Mild Alzheimer’s Disease, Further Supporting Precision Medicine Approach and Planned Confirmatory Clinical Trial with ALZ-801

Presentation at the Alzheimer’s Association International Conference Details Patient Responder Analyses on Key Clinical Outcomes.

July 23, 2018
·
5 min read
Business

Gamida Cell Expands Leadership Team with Appointments of Tzvi Palash as Chief Operating Officer and John Schick as Vice President of Market Access

Gamida Cell today announced the appointments of Tzvi Palash as chief operating officer (COO) and John D. Schick as vice president, market access.

July 23, 2018
·
2 min read